REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients.
about
Glutamine supplementation for critically ill adultsGlutamine supplementation for critically ill adultsNutrition: A Primary Therapy in Pediatric Acute Respiratory Distress SyndromeOxidative Stress and Therapeutic Development in Lung DiseasesRationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineImproving the Practice of Nutrition Therapy in the NRITLD Critically Ill Patients: An International Quality Improvement Project.Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cellsFluid management in major burn injuries.The Japanese guidelines for the management of sepsis.Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trialsAnti-Inflammatory Effect of Taurine in Burned Patients.Enteral glutamine: a novel mediator of PPARgamma in the postischemic gutImmune-modulating enteral formulations: optimum components, appropriate patients, and controversial use of arginine in sepsis.The role of nutrients in modulating disease.The enteral vs parenteral nutrition debate revisited.Antioxidants and micronutrient supplementation in trauma patients.Update on postinjury nutrition.Nutrition in the intensive care unit: year in review 2008-2009.Molecular mechanisms of pharmaconutrients.Understanding the mechanisms of glutamine action in critically ill patients.Innate immunity signaling pathways: links between immunonutrition and responses to sepsis.Selenium supplementation in the critically ill.Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis.Pharmaconutrition with selenium in critically ill patients: what do we know?Disease-specific nutrition therapy: one size does not fit all.Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.Postinjury Inflammation and Organ Dysfunction.Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial.Glutamine supplementation.Glutamine prevents oxidative stress in a model of portal hypertensionSafety and Dose Escalation Study of Intravenous Zinc Supplementation in Pediatric Critical Illness.Oral glutamine attenuates cyclophosphamide-induced oxidative stress in the bladder but does not prevent hemorrhagic cystitis in ratsImmunonutrition: Role in Wound Healing and Tissue Regeneration.Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?Pharmacologically dosed oral glutamine reduces myocardial injury in patients undergoing cardiac surgery: a randomized pilot feasibility trial.Efficacy of commercial formulas in comparison with home-made formulas for enteral feeding: A critical review.Volume Resuscitation in Patients With High-Voltage Electrical Injuries.Food and Drug Administration Approval of Glutamine for Sickle Cell Disease: Success and Precautions in Glutamine Research.Oxidative stress in critical care medicine
P2860
Q24193714-0F349E74-8489-4F33-8114-BDF7F76D7933Q24201244-AFDB8E66-5536-4037-9DDF-C12A6B99E201Q28069270-0D01E461-F1A6-4CAB-95D9-AC867B4BABCAQ28390572-ADA9B749-5512-4A48-AA35-A12CF09AFB4BQ30435166-2903C969-5BBA-49AB-8B50-1B7B54880F87Q33974292-342E2B1B-4466-427C-8208-05624078575AQ34126425-0C4C0610-F258-4443-B5EE-36BDF339E47FQ34425930-6E4DFBC8-A0D5-4C92-9297-8253E613AAD6Q34571518-A5B87CEE-6BA5-4569-ADF3-DB2C989DE5C9Q35107094-19D4EF94-87C9-4E95-BF79-DBBCB251AF2DQ35559489-5EAF84A6-8103-4F52-A910-A8AAF8C0788DQ36509491-34C6C6FB-8926-4AF8-B797-3FF75E95DF5FQ36838550-C2B39613-79F8-404F-B06E-6C956831A6EEQ36947400-AAC48B7B-D4EF-4EC9-A051-AE8FEF1F7E30Q37176474-59FCBF79-5F43-4631-9C5F-60BE5BB3CA9BQ37205511-880127D9-6368-48C2-841B-735F5007547DQ37238417-268C18F4-4CDF-481F-B08B-631C233B7CF2Q37324096-7FD2E28F-F226-430B-943E-D3706178CE81Q37669609-6E9B446F-36E6-489E-B851-DCEA6FE2D467Q37676616-FBC80A58-B094-4EC3-81EE-4C66DF0121E1Q37766464-BDB62356-1D77-4084-A322-F137ED19D880Q37836563-84CE3AE5-6C8A-48A5-A42E-55D7861E5F76Q37981599-3299E4B1-B5D0-49C7-90EF-9A6AD1E89D63Q38005555-8A580F9D-912D-48F3-9274-8610EF48D8B8Q38294307-2619A3FA-E8C7-4378-9DE7-5C10E5BBBEE1Q38713104-4DB0936F-3962-4E94-BF6E-D164652F4199Q38751931-1CE2FA84-DAED-4579-A6D2-43BE6EB489D7Q39022520-14314F4D-7391-4316-94F9-3A3762E4742DQ39272777-83A8AE40-7B62-4B4C-9363-F790CFCE9C78Q39386551-0267E3C7-D404-44DB-B86C-DBB2E9E61ADCQ40976036-A746A14E-A36C-4490-B56B-2F6D74339616Q41700609-8F5EB063-8272-4493-B7A9-2FCCE9C7E5D7Q41971692-BE1D3B73-D490-4DE6-B4C7-B0154724CA37Q42735997-0154F8A2-C6BA-4D85-8D81-381653E66755Q42963860-74C228D2-1905-4301-A6A8-FC7EA8EA28C9Q47720547-1B1404BE-B906-4EB3-A38F-443B883004E4Q49486199-85A298C2-EA32-48E6-893B-7D89DB493795Q49814797-7A25CDBD-DB24-4FEB-9448-5FAB6A7C8F0FQ50246036-C78D027A-679E-41A7-B2D4-77408B5A7B4FQ57527109-61062321-9CDF-4EC3-8A1B-0BEAA86DC4CB
P2860
REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
REducing Deaths due to OXidati ...... on in critically-ill patients.
@ast
REducing Deaths due to OXidati ...... on in critically-ill patients.
@en
type
label
REducing Deaths due to OXidati ...... on in critically-ill patients.
@ast
REducing Deaths due to OXidati ...... on in critically-ill patients.
@en
prefLabel
REducing Deaths due to OXidati ...... on in critically-ill patients.
@ast
REducing Deaths due to OXidati ...... on in critically-ill patients.
@en
P2093
P356
P1476
REducing Deaths due to OXidati ...... on in critically-ill patients.
@en
P2093
Andrew G Day
Canadian Critical Care Trials Group
Daren K Heyland
Deborah Cook
John Drover
John Muscedere
Rupinder Dhaliwal
Ulrich Suchner
P304
P356
10.1079/PNS2006505
P577
2006-08-01T00:00:00Z